Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games
Effects of Different Parameter Settings on the Classification Accuracy of P300-BCI Speller in Elderly Adults with and Without Mild Cognitive Impairments
1 other identifier
observational
15
1 country
1
Brief Summary
The study will investigate the use of Electroencephalography (EEG) in understanding mild cognitive impairment (MCI). EEG is commonly used in everyday clinical practice for the assessment of a wide range of neurological disorders. It records the brains spontaneous electrical signals and offers a non-invasive means of visually evaluating brain signals. By analysing these signals, we aim to uncover invaluable insights into cognitive impairments and the ageing brains cognitive processes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2025
CompletedOctober 8, 2024
September 1, 2024
7 months
September 25, 2024
October 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of the Brain-Computer Interface (BCI) model across different settings which is being tested
This outcome measure will assess the accuracy of the P300-based Brain-Computer Interface (BCI) system across different settings being tested. Using state-of-the-art BCI classification models, the accuracy of P300-BCI system classification will be determined through offline analysis of EEG data collected during the experiment.
Through study completion, an average of 9 months.
Secondary Outcomes (6)
The scores of the Montreal Cognitive Assessment (MoCA)
Through study completion, an average of 9 months.
Reaction times of the Random Dot Motion (RDM) test
Through study completion, an average of 9 months.
Error rates of the Random Dot Motion (RDM) test
Through study completion, an average of 9 months.
Characteristics of the P300 amplitude across different settings
Through study completion, an average of 9 months.
Characteristics of the P300 latency across different settings
Through study completion, an average of 9 months.
- +1 more secondary outcomes
Study Arms (1)
Elderly with Mild Cognitive Impairments
Interventions
MoCA (Montreal Cognitive Assessment or The MoCA Test) was validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in hundreds of peer-reviewed studies since 2000. MoCA has been widely adopted in clinical settings and used in academic and non-academic research around the world. The sensitivity of MoCA for detecting MCI is 90%, compared to 18% for the MMSE. Prospective participants meeting the eligibility criteria, as determined by the Montreal Cognitive Assessment (MoCA) test, will be invited to the Brain- Computer Interface (BCI) laboratory at the Kroto Research Centre on the University of Sheffield north campus to participate in the study.
Random Dot Motion task (RDM) has been widely used in research on spatial attention, and decision-making ability, etc., and its results (accuracy and reaction time) can be used as indicators to detect spatial attention. During the assessment, participants were required to monitor a series of dots in constant random motion on the screen. The dots sometimes moved coherently together to the left or right, and participants were required to press the left mouse button when they perceived them moving to the left and the right mouse button when they observed them moving to the right. We are going to use the motion coherence level of 50%. The higher the coherence level, the greater the number of dots moving together, and the combination of the moving direction and coherence level of the dots appear randomly during the task.
Two different speller matrix sizes: 3×3 and 5×5, two inter-stimulus intervals (ISIs): 117ms (i.e., commonly used ISI for healthy adults) and 175ms (i.e., 50% longer than the widely used ISI) and two spelling words (QUICK and JUMP) are designed in this experiment to explore the calibration accuracy of these eight parameter combinations in the young and old groups and obtain the best parameter combination. The matrix contains letters and digits, and the target letters will be displayed below the matrix letter by letter. When the speller runs, the rows and columns in the matrix will flash 15 times each randomly. Each flash will last for 55ms, and the subsequent ISI will last for different times according to different parameter designs. Participants only need to focus on the target letter and silently count the number it flashes, as flashing target letters can generate P300 if well attended.
Eligibility Criteria
Participants will be from the Sheffield Memory Clinic run by Dr Blackburn. This sees approximately 400 new patients per year of whom 15-20% have MCI, it is a research active clinic, and we have a database of people interested in taking part in research. Suitable participants will be identified in the clinic by a member of their clinical staff or contacted from their database.
You may qualify if:
- Diagnosed with mild cognitive impairments (MCI) or mild dementia
- Normal or corrected-to-normal vision
- Can maintain sitting with or without support for around 60 minutes continuously
- Cognitive and language abilities to understand and participate in the study protocol and able to give consent and understand instructions
You may not qualify if:
- Severe cognitive impairment that would interfere with their ability to comply with the experimental protocol or provide informed consent
- Pre-existing severe systemic disorders like active cancer, end-stage pulmonary or cardiovascular disease, psychiatric illness including severe alcohol or drug abuse
- Past history of epilepsy- with seizures in last 12 months
- History of photosensitive epilepsy.
- Allergy to latex
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Sheffield
Sheffield, South Yorkshire, S3 7ES, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahnaz Arvaneh
University of Sheffield
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2024
First Posted
October 8, 2024
Study Start
October 15, 2024
Primary Completion
May 14, 2025
Study Completion
July 14, 2025
Last Updated
October 8, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
We plan to share anonymized data from the study, including raw EEG data and relevant metadata. The data will be available starting six months after publication and will remain accessible for a period of five years. Researchers who wish to access the data will be required to submit a formal request, and access will be granted upon approval by our data access committee.